Center for Research and Production of Vaccines and Biologicals (POLYVAC) has conducted “Study on the production process of single dose measles-rubella combined vaccine (MRVAC)” (1dose/vial) in lyophilized form to make it convenient to use for vaccination services and export. The results have determined the formulation of MRVAC final bulk, freeze-dried process. The quality of researched products met WHO and Vietnam Pharmacopoeia V standards in both visual tests of lyophilized vaccine cake and after being reconstituted with sterile water for injection, the titer of measles virus ranges from 4.03 to 4.28 lgPFU/0.5mL and titer of rubella virus is from 3.79 to 3.98 lgPFU/0.5 mL. Results on thermal stability test when incubating the vaccine at 37oC/7days, the titer of measles virus decreased from 0.79 to 0.96 lgPFU/ 0.5mL and titer of rubella virus decreased from 0 to 0.18 lgPFU/0.5mL. Residual moisture content ranges from 0.35 to 0.72%. pH of vaccine is stable, ranges from 7.42 to 7.62.
STUDY ON THE PRODUCTION PROCESS OF SINGLE DOSE MEASLES-RUBELLA COMBINED VACCINE AT POLYVAC
20
Views
18
Downloads
Keywords
Measles – Rubella combined vaccine, MRVAC, freeze-dried
Abstract
References
[1]
Huyen DTT, Hong DT, Some clinical and epidemiological characteristics of measles in Vietnam, 2013-2014, Vietnam Journal of Preventive Medicine, 2016; 26(4): 98-106.
Google Scholar
[2]
Vietnamese Pharmacopoeia, 5th Edition, Vietnam Medical Publishing Hourse, 2018.
Google Scholar
[3]
Ministry of Health, Regulations on registration of drugs and medicinal ingredients. Circular: 32/2018/TT-BYT, 2018.
Google Scholar
[4]
Huong NT, Thu PA, Huong NTT, Huong VT et al., Thermo - Stability of measles-rubella combined vaccine produced at Polyvac, Vietnam Journal of Preventive Medicine, 2018; 28(4): 52-57. (in Vietnamese)
Google Scholar
[5]
Kieu NT, Thermo - Stability of measles vaccine produced in Vietnam. Doctoral thesis, Hanoi Medical University, 2014. (in Vietnamese)
Google Scholar
[6]
World Heath Oganization, Requirements for measles, mumps and rubella vaccines and combined vaccine, WHO Technical Report Series, No. 840, Annex 3, 1994.
Google Scholar
[7]
World Heath Oganization, WHO Technical Report Series, No. 993, Annex 4, 2015.
Google Scholar
[8]
Andrea G, Freeze-drying process principle and practice, 2010.
Google Scholar
[9]
Xu B, Wang T, Zhou Y et al., Optimization of procedure for lyophilization of live attenuated measles vaccine, Chinese Journal of Biologicals, 2010; 23(12): 1343-1346.
Google Scholar
[11]
accessed on 14th Feb 2021.
Google Scholar